Ajanta Pharma Q3 Results: Net Profit Up 11% At Rs 233 Crore

Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.

PTI

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11% on-year to Rs 233 crore for the third quarter ended Dec. 31, 2024.

(Source: Ajanta Pharma website)

Ajanta Pharma on Thursday said its consolidated profit after tax increased by 11% on-year to Rs 233 crore for the third quarter ended Dec. 31, 2024. The drug firm had reported a profit of Rs 210 crore in the October-December period of last fiscal.

Revenue from operations stood at Rs 1,146 crore in the third quarter compared to Rs 1,105 crore in the year-ago period, Ajanta Pharma said in a regulatory filing.

Shares of the company settled 1.64 per cent higher at Rs 2,670.70 apiece on the BSE.

Also Read: Tata Consumer Products Q3 Results: Profit Flat, Revenue Up 17%

Watch LIVE TV, Get Stock Market Updates, Top Business, IPO and Latest News on NDTV Profit. Feel free to Add NDTV Profit as trusted source on Google.
GET REGULAR UPDATES
Add us to your Preferences
Set as your preferred source on Google